Company | Background | Management | Advisors

The use of aborted fetal tissue and embryonic cells in the discovery, development, and production of vaccines and pharmaceuticals has increased dramatically in the past decade. These practices make it difficult for many physicians, pharmacists, scientists and healthcare professionals to navigate their fields of expertise without sacrificing their consciences. One does not need to share another’s moral convictions to be convinced of the rights of others to hold those moral convictions. 

Pharmaceutical and biotechnology companies brought new, critically needed therapeutics to market at a remarkable rate for many decades before the use of aborted fetal or embryonic material was introduced. Despite the current prevalence of aborted fetal and embryonic material in drug discovery, development, and production, new drug approvals have now fallen to all-time lows. 

AVM Biotechnology knows that there is a solution at hand for this dilemma of professional career versus conscience. Physicians, pharmacists and healthcare professionals must be provided with the tools and medicines they need to practice fully their calling, without sacrificing either professional opportunities or conscience. The technology to do this exists.

AVM Biotechnology intends to harness that technology and provide safe, effective, affordable and moral therapeutics.

Home|Background|Management|Advisors|Vaccines|Regenerative Medicine|Media|Research|Words of Support |Contact

Disclaimer | AVM Biotechnology | Eklind Hall | 1102 Columbia Street, Suite 316 | Seattle, WA 98104 | 206-906-9922| | © Copyright 2010 AVM Biotechnology, LLC